Amyris and CJ CheilJedang to support the growing bioeconomy in Asia

image
John Melo, Ceo of Amyris

Amyris, the industrial bioscience company based in California, and South Korea-based CJ CheilJedang Corporation last Friday announced that the companies have signed a Memorandum of Understanding (MOU) to support large-scale manufacturing of Amyris’s farnesene, a fuel sourced from sugar cane, in existing CJ facilities.

Continue reading

Amyris and Squalan enter into agreements for the production and marketing of bio-based personal care products

 

John Melo, Ceo of Amyris
John Melo, Ceo of Amyris

Amyris, Inc., a global renewable products company providing sustainable alternatives to a variety of non-renewable resources, and Squalan Natural Health B.V., a privately held, personal care product company based in The Netherlands, have entered into agreements for the production and marketing of Neossance Squalane-based personal care products.

The partnership between Amyris and Squalan accelerates development and market penetration of skin care and personal care products containing Amyris’s Neossance Squalane, which is produced from plant sugars. Under this new relationship, Squalan will market and sell Neossance-based products to retailers and consumers, primarily in the European Union.

Continue reading

Total and Amyris bio-based jet fuel ready for use in commercial aviation

image
Total's headquarter in Paris

Total, one of the world’s leading energy companies, and Amyris, an industrial bioscience company, begin to prepare to market a drop in jet fuel that contains up to 10% blends of renewable farnesane. This new jet fuel blend meets the rigorous performance requirements set for Jet A/A-1 fuel used by the global commercial aviation industry. 

Continue reading

Amyris aims at becoming a great player in the bioeconomy. Together with Firmenich and Total

Bill and Melinda Gates: their Foundation supported the start-up of Amyris in 2005
Bill and Melinda Gates: their Foundation supported the start-up of Amyris in 2005

The US biotech company Amyris aims at becoming a great player in the world bioeconomy. Founded in 2003 in the San Francisco Bay Area by a group of scientists at the University of California, Berkeley, Amyris – as anticipated during its prior quarter results call – has begun the production of its first fragrance oil at a specialty contract manufacturing facility. In 2014, building on the successful results of its initial fragrance oil production and based on feedback from its partner, Amyris plans to also produce this fragrance oil at its own Brotas production facility. The Brotas biorefinery currently produces Biofene, Amyris’s brand of farnesene, a renewable hydrocarbon used for a range of applications. Following planned improvements to the Brotas plant in early 2014, Amyris expects to be able to produce both Biofene and a range of other fermentation products, including its fragrance oils, at the plant.

This announcement follows the one of last December, when Amyris announced together with the French oil giant Total the formation of Total Amyris Biosolutions, a 50-50 joint venture that will produce market renewable diesel and jet fuel.

Continue reading